These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 37142282)

  • 1. Immune-mediated herb-induced liver injury: a potential association with herbal artemisinin use as supported by the updated RUCAM.
    Mathavan A; Mathavan A; Krekora U; Daily K
    BMJ Case Rep; 2023 May; 16(5):. PubMed ID: 37142282
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Herb-induced liver injury (HILI) with 12,068 worldwide cases published with causality assessments by Roussel Uclaf Causality Assessment Method (RUCAM): an overview.
    Teschke R; Eickhoff A; Schulze J; Danan G
    Transl Gastroenterol Hepatol; 2021; 6():51. PubMed ID: 34423172
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Corticosteroid plus glycyrrhizin therapy for chronic drug- or herb-induced liver injury achieves biochemical and histological improvements: a randomised open-label trial.
    Wang JB; Huang A; Wang Y; Ji D; Liang QS; Zhao J; Zhou G; Liu S; Niu M; Sun Y; Tian H; Teng GJ; Chang BX; Bi JF; Peng XX; Xin S; Xie H; Ma X; Mao YM; Liangpunsakul S; Saxena R; Aithal GP; Xiao XH; Zhao J; Zou Z
    Aliment Pharmacol Ther; 2022 May; 55(10):1297-1310. PubMed ID: 35362188
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Advances in Idiosyncratic Drug-Induced Liver Injury Issues: New Clinical and Mechanistic Analysis Due to Roussel Uclaf Causality Assessment Method Use.
    Teschke R; Danan G
    Int J Mol Sci; 2023 Jun; 24(13):. PubMed ID: 37446036
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Causality assessment of herb-induced liver injury using multidisciplinary approach and Roussel Uclaf Causality Assessment Method (RUCAM).
    Nin Chau T; Cheung WI; Ngan T; Lin J; Lee KW; Tat Poon W; Leung VK; Mak T; Tse ML;
    Clin Toxicol (Phila); 2011 Jan; 49(1):34-9. PubMed ID: 21114414
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Drug-Induced Liver Injury: Why is the Roussel Uclaf Causality Assessment Method (RUCAM) Still Used 25 Years After Its Launch?
    Danan G; Teschke R
    Drug Saf; 2018 Aug; 41(8):735-743. PubMed ID: 29502198
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New Insights into Herb-Induced Liver Injury.
    Ma ZT; Shi Z; Xiao XH; Wang JB
    Antioxid Redox Signal; 2023 Jun; 38(16-18):1138-1149. PubMed ID: 36401515
    [No Abstract]   [Full Text] [Related]  

  • 8. Idiosyncratic Drug-Induced Liver Injury (DILI) and Herb-Induced Liver Injury (HILI): Diagnostic Algorithm Based on the Quantitative Roussel Uclaf Causality Assessment Method (RUCAM).
    Teschke R; Danan G
    Diagnostics (Basel); 2021 Mar; 11(3):. PubMed ID: 33800917
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Herb induced liver injury by Xianling Gubao Tablets: A case assessed for causality using updated RUCAM and integrated evidence chain.
    Li C; Li Y; Bai Z; Wang J; Li G; Xiao X
    Chin Herb Med; 2024 Apr; 16(2):301-309. PubMed ID: 38706827
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Certolizumab-induced liver injury: as assessed for causality by the updated RUCAM.
    Shakhashiro M; Crasta R; Javed F
    BMJ Case Rep; 2023 Sep; 16(9):. PubMed ID: 37748817
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Androgenic anabolic steroid-induced liver injury: two case reports assessed for causality by the updated Roussel Uclaf Causality Assessment Method (RUCAM) score and a comprehensive review of the literature.
    Abeles RD; Foxton M; Khan S; Goldin R; Smith B; Thursz MR; Verma S
    BMJ Open Gastroenterol; 2020 Nov; 7(1):. PubMed ID: 33214235
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Herb-induced autoimmune-like hepatitis associated with Xiang-tian-guo (Swietenia macrophylla seeds): A case report and literature review.
    Shao YM; Zhang Y; Yin X; Qin TT; Jin QL; Wen XY
    Medicine (Baltimore); 2021 Jan; 100(2):e24045. PubMed ID: 33466156
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ashwagandha-induced liver injury-A case series from India and literature review.
    Philips CA; Valsan A; Theruvath AH; Ravindran R; Oommen TT; Rajesh S; Bishnu S; Augustine P;
    Hepatol Commun; 2023 Oct; 7(10):. PubMed ID: 37756041
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Causality assessment of skyfruit-induced liver injury using the updated RUCAM: a case report and review of the literature.
    Xia C; Liu Y; Yao H; Zhu W; Ding J; Jin J
    J Int Med Res; 2020 Apr; 48(4):300060520917569. PubMed ID: 32293220
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Worldwide Use of RUCAM for Causality Assessment in 81,856 Idiosyncratic DILI and 14,029 HILI Cases Published 1993-Mid 2020: A Comprehensive Analysis.
    Teschke R; Danan G
    Medicines (Basel); 2020 Sep; 7(10):. PubMed ID: 33003400
    [No Abstract]   [Full Text] [Related]  

  • 16. Herbal Hepatotoxicity: Clinical Characteristics and Listing Compilation.
    Frenzel C; Teschke R
    Int J Mol Sci; 2016 Apr; 17(5):. PubMed ID: 27128912
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Causality imputation between herbal products and HILI: An algorithm evaluation in a systematic review.
    Soares PF; Fernandes MTCF; Souza AS; Lopes CM; Dos Santos DAC; Oliveira DPR; Pereira MG; Prado NMBL; Gomes GSDS; Santos G; Paraná R
    Ann Hepatol; 2021; 25():100539. PubMed ID: 34555512
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Herb-Induced Liver Injury by Ayurvedic Ashwagandha as Assessed for Causality by the Updated RUCAM: An Emerging Cause.
    Bokan G; Glamočanin T; Mavija Z; Vidović B; Stojanović A; Björnsson ES; Vučić V
    Pharmaceuticals (Basel); 2023 Aug; 16(8):. PubMed ID: 37631044
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epidemiology of Drug- and Herb-Induced Liver Injury Assessed for Causality Using the Updated RUCAM in Two Hospitals from China.
    Chen Y; Wang C; Yang H; Huang P; Shi J; Tong Y; Jiang J; Zhang X; Chen W; Xuan Z
    Biomed Res Int; 2021; 2021():8894498. PubMed ID: 33954202
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Severe tyrosine-kinase inhibitor induced liver injury in metastatic renal cell carcinoma patients: two case reports assessed for causality using the updated RUCAM and review of the literature.
    Studentova H; Volakova J; Spisarova M; Zemankova A; Aiglova K; Szotkowski T; Melichar B
    BMC Gastroenterol; 2022 Feb; 22(1):49. PubMed ID: 35123392
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.